Jeffrey Trigilio
Chief Executive Officer at Cullinan Mica Corp.
Net worth: 2 M $ as of 2024-03-30
Jeffrey Trigilio active positions
Companies | Position | Start | End |
---|---|---|---|
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology PDI Therapeutics, Inc. develops therapeutics that enhances the body’s ability to recognize and destroy tumor cells. The company is headquartered in La Jolla, CA. | Chief Executive Officer | - | - |
Director of Finance/CFO | - | - | |
Corporate Secretary | - | - |
Career history of Jeffrey Trigilio
Former positions of Jeffrey Trigilio
Companies | Position | Start | End |
---|---|---|---|
CULLINAN THERAPEUTICS, INC. | Director of Finance/CFO | 2020-08-31 | 2024-03-28 |
Treasurer | - | 2024-03-28 | |
AMYLYX PHARMACEUTICALS, INC. | Director of Finance/CFO | 2019-12-31 | 2020-06-30 |
Bluerock Therapeutics, Inc. | Corporate Officer/Principal | 2018-07-31 | 2019-12-31 |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance RBC Capital Markets LLC is a full-service brokerage and financial services firm headquartered in New York City. They are a direct subsidiary of RBC USA Holdco Corp. and a wholly-owned indirect subsidiary of Royal Bank of Canada (TSE, NYSE: RY). Founded in 2010, the firm is comprised of 3 major business lines: the Private Client Group, the Fixed-Income Group and the Clearing and Execution Services Group. The Private Client Group serves individual investors, while the Fixed-Income Group provides services to institutions, municipalities and non-profit organizations. The Clearing and Execution Services Group is a provider of clearing and execution services to independent brokers/dealers throughout the US. RBC Capital Markets focuses on the following sectors: communications, media, consumer/retail, diversified industries, energy, financial institutions, forest products, healthcare, infrastructure finance, mining & metals, real estate, social infrastructure, technology and the US municipal markets. | Corporate Officer/Principal | 2017-10-31 | 2018-07-31 |
BAYER AG | Sales & Marketing | - | - |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 2020-08-31 | - |
Training of Jeffrey Trigilio
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Cornell University | Undergraduate Degree |
Statistics
International
United States | 9 |
Germany | 2 |
Operational
Director of Finance/CFO | 4 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
BAYER AG | Health Technology |
AMYLYX PHARMACEUTICALS, INC. | Health Technology |
CULLINAN THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance RBC Capital Markets LLC is a full-service brokerage and financial services firm headquartered in New York City. They are a direct subsidiary of RBC USA Holdco Corp. and a wholly-owned indirect subsidiary of Royal Bank of Canada (TSE, NYSE: RY). Founded in 2010, the firm is comprised of 3 major business lines: the Private Client Group, the Fixed-Income Group and the Clearing and Execution Services Group. The Private Client Group serves individual investors, while the Fixed-Income Group provides services to institutions, municipalities and non-profit organizations. The Clearing and Execution Services Group is a provider of clearing and execution services to independent brokers/dealers throughout the US. RBC Capital Markets focuses on the following sectors: communications, media, consumer/retail, diversified industries, energy, financial institutions, forest products, healthcare, infrastructure finance, mining & metals, real estate, social infrastructure, technology and the US municipal markets. | Finance |
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology PDI Therapeutics, Inc. develops therapeutics that enhances the body’s ability to recognize and destroy tumor cells. The company is headquartered in La Jolla, CA. | Health Technology |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
Bluerock Therapeutics, Inc. |
- Stock Market
- Insiders
- Jeffrey Trigilio
- Experience